Articles & Video
Sponsors running multi country trials must guard against bribery
Globalization of drug research has increased the likelihood of bribery according to new analysis, which suggests the risk is greatest for international, multi-center trials.
Syneos buys StudyKIK in latest move to grow decentralized trials business
Syneos Health has acquired clinical trial recruitment firm StudyKIK, citing its recruitment and retention technologies as the driver.
WCG combines Avoca and MCC citing benefits of collaboration
WCG has combined recent acquisition the Avoca Quality Consortium with the Metrics Champion Consortium (MCC), its clinical trial metrics operation.
Pfizer: Trial management and manufacturing key to DMD gene therapy success
Pfizer has stressed the importance of its global trial management as it looks to be first to market with its gene therapy for Duchenne muscular dystrophy (DMD).
Remote working has not hurt clinical trial sector productivity, Tufts
Clinical research staff who switched to remote working as a result of the pandemic maintained productivity levels but felt less connected, according to new research.
Science 37 and Foundation Medicine to speed decentralized trial recruitment
Science 37 and Foundation Medicine have partnered to help drug developers accelerate enrolment in decentralized clinical trials.
MMS launches free support program for ultra-rare diseases
MMS Holdings says a new support scheme will help trial medicines being developed for ultra-rare diseases.
Scope to help new JV Ketabon test oral ketamine for depression
Scope International will manage trials examining an oral formulation of the anesthetic ketamine as a treatment for depression under a contract with newly formed developer Ketabon.
Effective trial data management even more vital during COVID-19, says study
COVID-19 has underlined the importance of efficient, secure data management in clinical trials, according to research by IBM and US-based CRO Veristat.
COVID has set the stage for trials to go digital say researchers
Clinical trials will enter the digital age according to Indian researchers who say the COVID-19 pandemic has finally convinced CROs to swap pen and paper for data.
Trial starts above 2019 levels according to IQVIA
Clinical trial activity has recovered according to IQVIA, which raised its full year forecast citing new business wins by its study division as a major driver.
Clinlogix becomes third takeover in a year for device CRO NAMSA
Device CRO NAMSA says Clinlogix will extend its global reach and expand its range of disease expertise.
PRA and Icon’s order books boosted by COVID-19
PRA Health Sciences’ clinical business saw a surge in demand in the second quarter according to Icon, which highlighted its new acquisition as a major growth driver.
KoreaBio: COVID-19 driving CRO sector M&A surge
The CRO sector has grown during the COVID-19 pandemic, with higher demand – particularly for decentralized studies –increasing M&A activity according to industry group KoreaBio.
Welocalize buys CRO-focused translation firm Next Level Globalization
Translation firm Welocalize has bought CRO and pharma focused language services organization Next Level Globalization (NLG).
Premier Research buys Health Decisions citing women’s health market
Premier Research has acquired women’s health and diagnostics specialist Health Decisions, citing the market as a major opportunity.
Thermo says cell and gene therapy and PPD key to further growth in 2021
Thermo Fisher Scientific says cell and gene therapy contracting, PPD and ongoing CAPEX investments will drive growth.
WCG buys VeraSci in second acquisition in weeks
WCG has acquired eClinical software firm VeraSci, expanding its capabilities to support clinical trials focused on central nervous system (CNS) disorders.
Quanticate lauds benefits of its cloud trial data management platform
Quanticate says its new cloud-based data verification platform cuts trial costs and accelerates timelines.